This article has been corrected from a previous version because it referred to the local coverage determination on comprehensive genomic profiling for non-small cell lung cancer as a draft policy based on an earlier version of the document issued by Palmetto in error. Stakeholders can submit comments to the final LCD in the form of a "reconsideration."
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
You may already have institutional access!
Check if I qualify.
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.